Fiona Middleton Professor Nicola Curtin
| The impact of p53 dysfunction in ATR inhibitor cytotoxicity and chemo-and radiosensitisation | 2018 |
|
Fiona Middleton Dr Miranda Patterson Dr Claire Elstob Dr Sarah Fordham Dr Ashleigh Herriott et al. | Common cancer-associated imbalances in the DNA damage response confer sensitivity to single agent ATR inhibition | 2015 |
|
Dr Tao Chen Fiona Middleton Professor Nicola Curtin
| Development of pharmacodynamic biomarkers for ATR inhibitors | 2015 |
|
Fiona Middleton Dr Tao Chen Professor Nicola Curtin
| Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer | 2015 |
|
Fiona Middleton Dr Tao Chen Professor Nicola Curtin
| Investigating p53 and other potential determinants of cell sensitivity to ATR inhibition by VE-821 | 2014 |
|
Fiona Middleton Dr Tao Chen Professor Nicola Curtin
| p53 and other components of the DNA damage response as determinants of cell sensitivity to ATR inhibition | 2014 |
|
Fiona Middleton Professor Nicola Curtin
| ATR as a therapeutic target | 2013 |
|
Fiona Middleton Dr Tao Chen Professor Nicola Curtin
| Chemosensitisation By, and Single Agent Activity of, ATR Inhibitor VE-821 in Human Breast Cancer Cells | 2012 |
|
Dr Tao Chen Dr Peter Stephens Fiona Middleton Professor Nicola Curtin
| Targeting the S and G2 checkpoint to treat cancer | 2012 |
|